Indi-I think the big problem is that UNI is running behind the...

Indi-I think the big problem is that UNI is running behind the curve in getting a product completed and ready for trials. Many other companies have come into the party and are competing for the business with fully developed products. Even if UNI has a better mousetrap, the Pharmas may not be willing to wait another year or two or three. They will take what's available to get their drugs to market.

The money involved in these new drugs is so large that a few months delay to market can cost a Pharma 100's of millions in sales and profits. No device is worth waiting for and losing those profits.